Skip to Content
🌐Ship toSelect country

Juvederm Ultra 4 Lidocaine - 2 x 1,0ml

Juvéderm Ultra 4 is the highest-viscosity product in Allergan's Hylacross-based Ultra line, formulated at 24 mg/ml hyaluronic acid with 0.3% lidocaine. It is designed for deep dermal injection to correct pronounced facial folds and wrinkles — including nasolabial folds and marionette lines — and for volumising the cheeks, chin and lips. Its higher cohesiveness and viscoelasticity give it strong lifting capacity for more significant volume loss. Effects are immediate, with manufacturer and clinical sources citing duration of up to approximately 12 months. For use by licensed, trained medical practitioners only.

162.00 € 162.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand JUVÉDERM®
SKU A0104 Share
Treatment Areas CheeksChinJawlineNasolabial folds
Tags Cross-Linked Hyaluronic AcidDeep Wrinkles

Juvederm Ultra 4 is the firmest formulation in Allergan's Juvederm Ultra range, built on Hylacross technology, designed for correction of deeper facial wrinkles and folds and for facial contouring. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Hyaluronic acid 24mg/ml (Hylacross technology)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 9-12 months, depending on individual metabolism and treatment area.

INDICATIONS

  • Deep facial wrinkles and folds
  • Facial contouring

TREATMENT AREAS

  • Nasolabial folds
  • Cheeks
  • Face, general

Juvederm Ultra 4 is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin